aluates Reports

$ 0.0

Automative

Global Neuroscience Antibodies and Assays Technology Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-20V12876

Global Neuroscience Antibodies and Assays Technology Market Research Report 2022

BUY CHAPTERS

Global Neuroscience Antibodies and Assays Technology Market Research Report 2025

Code: QYRE-Auto-20V12876

Report

February 2025

Pages:81

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abcam

BioLegend

Siemens AG

Bio Rad

Genscript Biotech

Rockland Immunochemicals

Cell Signaling Technology

Merck

Tecan Group

Santa Cruz Biotechnology

Thermo Fisher Scientific

Enzo Life Sciences

Neuroscience Antibodies and Assays Technology Market

The global market for Neuroscience Antibodies and Assays Technology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Neuroscience antibodies and assays technology refers to the specialized tools and techniques used in neuroscience research to study and analyze proteins, biomolecules, and cellular processes in the nervous system. These technologies play a crucial role in understanding the complexities of the brain and its functions, including neuronal communication, synaptic signaling, and the underlying molecular mechanisms of neurological diseases and disorders.

The global market for neuroscience antibodies and assays technology has been witnessing substantial growth due to the increasing research activities in neuroscience, the rising prevalence of neurological disorders, and the advancements in life science technologies. Neuroscience antibodies and assays play a crucial role in understanding the complexities of the nervous system and exploring potential therapeutic targets for neurological diseases. The market for neuroscience antibodies and assays technology is significant in regions with strong research and healthcare infrastructures. North America, including the United States, has been a major contributor to the market due to its large base of research institutions and pharmaceutical companies focused on neuroscience. Europe and Asia-Pacific regions have also witnessed substantial growth in neuroscience research, driving the demand for neuroscience antibodies and assays technology.

This report aims to provide a comprehensive presentation of the global market for Neuroscience Antibodies and Assays Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroscience Antibodies and Assays Technology.

The Neuroscience Antibodies and Assays Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neuroscience Antibodies and Assays Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neuroscience Antibodies and Assays Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Neuroscience Antibodies and Assays Technology Market Report

Report Metric	Details
Report Name	Neuroscience Antibodies and Assays Technology Market
Segment by Type	Molecular Diagnostics Clinical Chemistry Immunoassay Immunochemistry Others
Segment by Application	Hospitals Diagnostics Center Pharmaceutical and Biotechnology Company Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abcam, BioLegend, Siemens, Bio-Rad, Genscript Biotech, Rockland Immunochemicals, Cell Signaling Technology, Merck, Tecan Group, Santa Cruz Biotechnology, Thermo Fisher Scientific, Enzo Life Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuroscience Antibodies and Assays Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Neuroscience Antibodies and Assays Technology Market report?

Ans: The main players in the Neuroscience Antibodies and Assays Technology Market are Abcam, BioLegend, Siemens, Bio-Rad, Genscript Biotech, Rockland Immunochemicals, Cell Signaling Technology, Merck, Tecan Group, Santa Cruz Biotechnology, Thermo Fisher Scientific, Enzo Life Sciences

What are the Application segmentation covered in the Neuroscience Antibodies and Assays Technology Market report?

Ans: The Applications covered in the Neuroscience Antibodies and Assays Technology Market report are Hospitals, Diagnostics Center, Pharmaceutical and Biotechnology Company, Others

What are the Type segmentation covered in the Neuroscience Antibodies and Assays Technology Market report?

Ans: The Types covered in the Neuroscience Antibodies and Assays Technology Market report are Molecular Diagnostics, Clinical Chemistry, Immunoassay, Immunochemistry, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Molecular Diagnostics

1.2.3 Clinical Chemistry

1.2.4 Immunoassay

1.2.5 Immunochemistry

1.2.6 Others

1.3 Market by Application

1.3.1 Global Neuroscience Antibodies and Assays Technology Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Diagnostics Center

1.3.4 Pharmaceutical and Biotechnology Company

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Neuroscience Antibodies and Assays Technology Market Perspective (2020-2031)

2.2 Global Neuroscience Antibodies and Assays Technology Growth Trends by Region

2.2.1 Global Neuroscience Antibodies and Assays Technology Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Neuroscience Antibodies and Assays Technology Historic Market Size by Region (2020-2025)

2.2.3 Neuroscience Antibodies and Assays Technology Forecasted Market Size by Region (2026-2031)

2.3 Neuroscience Antibodies and Assays Technology Market Dynamics

2.3.1 Neuroscience Antibodies and Assays Technology Industry Trends

2.3.2 Neuroscience Antibodies and Assays Technology Market Drivers

2.3.3 Neuroscience Antibodies and Assays Technology Market Challenges

2.3.4 Neuroscience Antibodies and Assays Technology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Neuroscience Antibodies and Assays Technology Players by Revenue

3.1.1 Global Top Neuroscience Antibodies and Assays Technology Players by Revenue (2020-2025)

3.1.2 Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Players (2020-2025)

3.2 Global Neuroscience Antibodies and Assays Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Neuroscience Antibodies and Assays Technology Revenue

3.4 Global Neuroscience Antibodies and Assays Technology Market Concentration Ratio

3.4.1 Global Neuroscience Antibodies and Assays Technology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Neuroscience Antibodies and Assays Technology Revenue in 2024

3.5 Global Key Players of Neuroscience Antibodies and Assays Technology Head office and Area Served

3.6 Global Key Players of Neuroscience Antibodies and Assays Technology, Product and Application

3.7 Global Key Players of Neuroscience Antibodies and Assays Technology, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Neuroscience Antibodies and Assays Technology Breakdown Data by Type

4.1 Global Neuroscience Antibodies and Assays Technology Historic Market Size by Type (2020-2025)

4.2 Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Type (2026-2031)

5 Neuroscience Antibodies and Assays Technology Breakdown Data by Application

5.1 Global Neuroscience Antibodies and Assays Technology Historic Market Size by Application (2020-2025)

5.2 Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Neuroscience Antibodies and Assays Technology Market Size (2020-2031)

6.2 North America Neuroscience Antibodies and Assays Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025)

6.4 North America Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Neuroscience Antibodies and Assays Technology Market Size (2020-2031)

7.2 Europe Neuroscience Antibodies and Assays Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025)

7.4 Europe Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size (2020-2031)

8.2 Asia-Pacific Neuroscience Antibodies and Assays Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size by Region (2020-2025)

8.4 Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Neuroscience Antibodies and Assays Technology Market Size (2020-2031)

9.2 Latin America Neuroscience Antibodies and Assays Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025)

9.4 Latin America Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size (2020-2031)

10.2 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025)

10.4 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abcam

11.1.1 Abcam Company Details

11.1.2 Abcam Business Overview

11.1.3 Abcam Neuroscience Antibodies and Assays Technology Introduction

11.1.4 Abcam Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)

11.1.5 Abcam Recent Development

11.2 BioLegend

11.2.1 BioLegend Company Details

11.2.2 BioLegend Business Overview

11.2.3 BioLegend Neuroscience Antibodies and Assays Technology Introduction

11.2.4 BioLegend Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)

11.2.5 BioLegend Recent Development

11.3 Siemens

11.3.1 Siemens Company Details

11.3.2 Siemens Business Overview

11.3.3 Siemens Neuroscience Antibodies and Assays Technology Introduction

11.3.4 Siemens Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)

11.3.5 Siemens Recent Development

11.4 Bio-Rad

11.4.1 Bio-Rad Company Details

11.4.2 Bio-Rad Business Overview

11.4.3 Bio-Rad Neuroscience Antibodies and Assays Technology Introduction

11.4.4 Bio-Rad Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)

11.4.5 Bio-Rad Recent Development

11.5 Genscript Biotech

11.5.1 Genscript Biotech Company Details

11.5.2 Genscript Biotech Business Overview

11.5.3 Genscript Biotech Neuroscience Antibodies and Assays Technology Introduction

11.5.4 Genscript Biotech Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)

11.5.5 Genscript Biotech Recent Development

11.6 Rockland Immunochemicals

11.6.1 Rockland Immunochemicals Company Details

11.6.2 Rockland Immunochemicals Business Overview

11.6.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Technology Introduction

11.6.4 Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)

11.6.5 Rockland Immunochemicals Recent Development

11.7 Cell Signaling Technology

11.7.1 Cell Signaling Technology Company Details

11.7.2 Cell Signaling Technology Business Overview

11.7.3 Cell Signaling Technology Neuroscience Antibodies and Assays Technology Introduction

11.7.4 Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)

11.7.5 Cell Signaling Technology Recent Development

11.8 Merck

11.8.1 Merck Company Details

11.8.2 Merck Business Overview

11.8.3 Merck Neuroscience Antibodies and Assays Technology Introduction

11.8.4 Merck Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)

11.8.5 Merck Recent Development

11.9 Tecan Group

11.9.1 Tecan Group Company Details

11.9.2 Tecan Group Business Overview

11.9.3 Tecan Group Neuroscience Antibodies and Assays Technology Introduction

11.9.4 Tecan Group Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)

11.9.5 Tecan Group Recent Development

11.10 Santa Cruz Biotechnology

11.10.1 Santa Cruz Biotechnology Company Details

11.10.2 Santa Cruz Biotechnology Business Overview

11.10.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Technology Introduction

11.10.4 Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)

11.10.5 Santa Cruz Biotechnology Recent Development

11.11 Thermo Fisher Scientific

11.11.1 Thermo Fisher Scientific Company Details

11.11.2 Thermo Fisher Scientific Business Overview

11.11.3 Thermo Fisher Scientific Neuroscience Antibodies and Assays Technology Introduction

11.11.4 Thermo Fisher Scientific Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)

11.11.5 Thermo Fisher Scientific Recent Development

11.12 Enzo Life Sciences

11.12.1 Enzo Life Sciences Company Details

11.12.2 Enzo Life Sciences Business Overview

11.12.3 Enzo Life Sciences Neuroscience Antibodies and Assays Technology Introduction

11.12.4 Enzo Life Sciences Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)

11.12.5 Enzo Life Sciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abcam

BioLegend

Siemens AG

Bio Rad

Genscript Biotech

Rockland Immunochemicals

Cell Signaling Technology

Merck

Tecan Group

Santa Cruz Biotechnology

Thermo Fisher Scientific

Enzo Life Sciences

List of Tables

Table 1. Global Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Molecular Diagnostics

Table 3. Key Players of Clinical Chemistry

Table 4. Key Players of Immunoassay

Table 5. Key Players of Immunochemistry

Table 6. Key Players of Others

Table 7. Global Neuroscience Antibodies and Assays Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Neuroscience Antibodies and Assays Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Neuroscience Antibodies and Assays Technology Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Neuroscience Antibodies and Assays Technology Market Share by Region (2020-2025)

Table 11. Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Neuroscience Antibodies and Assays Technology Market Share by Region (2026-2031)

Table 13. Neuroscience Antibodies and Assays Technology Market Trends

Table 14. Neuroscience Antibodies and Assays Technology Market Drivers

Table 15. Neuroscience Antibodies and Assays Technology Market Challenges

Table 16. Neuroscience Antibodies and Assays Technology Market Restraints

Table 17. Global Neuroscience Antibodies and Assays Technology Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Neuroscience Antibodies and Assays Technology Market Share by Players (2020-2025)

Table 19. Global Top Neuroscience Antibodies and Assays Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays Technology as of 2024)

Table 20. Ranking of Global Top Neuroscience Antibodies and Assays Technology Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Neuroscience Antibodies and Assays Technology Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Neuroscience Antibodies and Assays Technology, Headquarters and Area Served

Table 23. Global Key Players of Neuroscience Antibodies and Assays Technology, Product and Application

Table 24. Global Key Players of Neuroscience Antibodies and Assays Technology, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Neuroscience Antibodies and Assays Technology Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Type (2020-2025)

Table 28. Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Type (2026-2031)

Table 30. Global Neuroscience Antibodies and Assays Technology Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Application (2020-2025)

Table 32. Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Application (2026-2031)

Table 34. North America Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031) & (US$ Million)

Table 49. Abcam Company Details

Table 50. Abcam Business Overview

Table 51. Abcam Neuroscience Antibodies and Assays Technology Product

Table 52. Abcam Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)

Table 53. Abcam Recent Development

Table 54. BioLegend Company Details

Table 55. BioLegend Business Overview

Table 56. BioLegend Neuroscience Antibodies and Assays Technology Product

Table 57. BioLegend Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)

Table 58. BioLegend Recent Development

Table 59. Siemens Company Details

Table 60. Siemens Business Overview

Table 61. Siemens Neuroscience Antibodies and Assays Technology Product

Table 62. Siemens Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)

Table 63. Siemens Recent Development

Table 64. Bio-Rad Company Details

Table 65. Bio-Rad Business Overview

Table 66. Bio-Rad Neuroscience Antibodies and Assays Technology Product

Table 67. Bio-Rad Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)

Table 68. Bio-Rad Recent Development

Table 69. Genscript Biotech Company Details

Table 70. Genscript Biotech Business Overview

Table 71. Genscript Biotech Neuroscience Antibodies and Assays Technology Product

Table 72. Genscript Biotech Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)

Table 73. Genscript Biotech Recent Development

Table 74. Rockland Immunochemicals Company Details

Table 75. Rockland Immunochemicals Business Overview

Table 76. Rockland Immunochemicals Neuroscience Antibodies and Assays Technology Product

Table 77. Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)

Table 78. Rockland Immunochemicals Recent Development

Table 79. Cell Signaling Technology Company Details

Table 80. Cell Signaling Technology Business Overview

Table 81. Cell Signaling Technology Neuroscience Antibodies and Assays Technology Product

Table 82. Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)

Table 83. Cell Signaling Technology Recent Development

Table 84. Merck Company Details

Table 85. Merck Business Overview

Table 86. Merck Neuroscience Antibodies and Assays Technology Product

Table 87. Merck Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)

Table 88. Merck Recent Development

Table 89. Tecan Group Company Details

Table 90. Tecan Group Business Overview

Table 91. Tecan Group Neuroscience Antibodies and Assays Technology Product

Table 92. Tecan Group Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)

Table 93. Tecan Group Recent Development

Table 94. Santa Cruz Biotechnology Company Details

Table 95. Santa Cruz Biotechnology Business Overview

Table 96. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Technology Product

Table 97. Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)

Table 98. Santa Cruz Biotechnology Recent Development

Table 99. Thermo Fisher Scientific Company Details

Table 100. Thermo Fisher Scientific Business Overview

Table 101. Thermo Fisher Scientific Neuroscience Antibodies and Assays Technology Product

Table 102. Thermo Fisher Scientific Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)

Table 103. Thermo Fisher Scientific Recent Development

Table 104. Enzo Life Sciences Company Details

Table 105. Enzo Life Sciences Business Overview

Table 106. Enzo Life Sciences Neuroscience Antibodies and Assays Technology Product

Table 107. Enzo Life Sciences Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)

Table 108. Enzo Life Sciences Recent Development

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

Table 112. Authors List of This Report

List of Figures

Figure 1. Neuroscience Antibodies and Assays Technology Picture

Figure 2. Global Neuroscience Antibodies and Assays Technology Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Neuroscience Antibodies and Assays Technology Market Share by Type: 2024 VS 2031

Figure 4. Molecular Diagnostics Features

Figure 5. Clinical Chemistry Features

Figure 6. Immunoassay Features

Figure 7. Immunochemistry Features

Figure 8. Others Features

Figure 9. Global Neuroscience Antibodies and Assays Technology Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Neuroscience Antibodies and Assays Technology Market Share by Application: 2024 VS 2031

Figure 11. Hospitals Case Studies

Figure 12. Diagnostics Center Case Studies

Figure 13. Pharmaceutical and Biotechnology Company Case Studies

Figure 14. Others Case Studies

Figure 15. Neuroscience Antibodies and Assays Technology Report Years Considered

Figure 16. Global Neuroscience Antibodies and Assays Technology Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Neuroscience Antibodies and Assays Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Neuroscience Antibodies and Assays Technology Market Share by Region: 2024 VS 2031

Figure 19. Global Neuroscience Antibodies and Assays Technology Market Share by Players in 2024

Figure 20. Global Top Neuroscience Antibodies and Assays Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays Technology as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Neuroscience Antibodies and Assays Technology Revenue in 2024

Figure 22. North America Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Neuroscience Antibodies and Assays Technology Market Share by Country (2020-2031)

Figure 24. United States Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Neuroscience Antibodies and Assays Technology Market Share by Country (2020-2031)

Figure 28. Germany Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Share by Region (2020-2031)

Figure 36. China Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Neuroscience Antibodies and Assays Technology Market Share by Country (2020-2031)

Figure 44. Mexico Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Share by Country (2020-2031)

Figure 48. Turkey Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Abcam Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)

Figure 52. BioLegend Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)

Figure 53. Siemens Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)

Figure 54. Bio-Rad Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)

Figure 55. Genscript Biotech Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)

Figure 56. Rockland Immunochemicals Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)

Figure 57. Cell Signaling Technology Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)

Figure 58. Merck Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)

Figure 59. Tecan Group Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)

Figure 60. Santa Cruz Biotechnology Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)

Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)

Figure 62. Enzo Life Sciences Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Antibodies Market Research Report 2024

Global Antibody Assay Service Market Research Report 2025

Neuroscience Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Research Antibodies Market Research Report 2025

Global Antibody Array Market Research Report 2025

Global Ready to Use Antibodies Market Research Report 2025

Global Neurological Biomarkers for Alzheimer s and Parkinson s Diseases Market Research Report 2025

Global Antibody Microarrays Market Research Report 2025

Global Monoclonal Antibodies Product Market Research Report 2024

Global Trial Size Antibodies Market Research Report 2024

Global BCAM Antibody Market Research Report 2024

Neuroscience Medical Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antibody Chips Market Research Report 2025

Global Bioassay Testing Market Research Report 2025

Global Secondary Antibodies Market Research Report 2025

Global EEG Biosensors Market Research Report 2025

Global Double Antibody Technology Platform Market Research Report 2025

Global Antibodies and Antigens to Cardiovascular Biomarkers Market Research Report 2025

Global Antibody Discovery Platforms Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions